Ameritas Investment Partners, Inc. Adverum Biotechnologies, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.34 $5,996 - $9,920	-7,403 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$10.3 - $21.64 $9,805 - $20,601	952 Added 14.76%	7,403 $76,000
Q2 2020 Aug 05, 2020	BUY	$8.53 - $25.64 $8,026 - $24,127	941 Added 17.08%	6,451 $135,000
Q1 2020 May 13, 2020	BUY	$7.98 - $16.32 $8,873 - $18,147	1,112 Added 25.28%	5,510 $54,000
Q2 2018 Aug 13, 2018	BUY	$5.3 - $6.9 $23,309 - $30,346	4,398 New	4,398 $23,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.